Life After Breast Cancer: Menopause, Bone Health, Fertility and Reconstruction

Treatment for breast cancer does not end with the last dose of chemotherapy or the last radiation session; several long-term issues need active management well beyond active treatment.

Managing menopausal symptoms

Many patients, especially younger ones, develop early menopausal symptoms during and after treatment. Minimising irritants, using adequate medication for local symptom control, limiting vaginal hormone use in appropriate cases, and considering psycho-oncology support and pelvic floor exercises can all help. These symptoms are often what brings patients back to their primary care physician during or after treatment, yet they can go unaddressed because patients feel reluctant to raise them or because they aren't prioritised in a busy cancer programme; in long-term survivors, they can persist for years, and both patients and their doctors sometimes don't realise how manageable they actually are.

Protecting bone health

Hormonal treatment in particular can weaken bones, and patients over 65 may already be at higher risk of osteoporosis before treatment even begins. Monitoring bone density with a BMD or DEXA scan, every two years or annually depending on the patient's baseline, should be prioritised, along with zoledronic acid, bisphosphonates or denosumab where indicated. Bone health can easily be overlooked at routine follow-up, but it needs attention for years after treatment ends.

Preserving fertility

Many patients wish to have children after treatment, and rising case numbers among young women make fertility preservation a real consideration. Chemotherapy can significantly affect ovulation and reproductive health, so the choice of chemotherapy drugs matters; cryopreservation or embryo preservation should be discussed with anyone who wants children later, and where that isn't possible before treatment starts, GnRH analogues given during chemotherapy help preserve ovarian function and reserve for a pregnancy attempted afterward. In select patients, even a temporary interruption of hormonal treatment has been tried to allow for pregnancy; early trial data suggests this does not meaningfully raise short-term recurrence risk, but it remains early evidence and should only be considered in direct consultation with the treating oncologist.

Reconstruction after mastectomy

For a patient scheduled for mastectomy and a sentinel lymph node biopsy who is concerned about her appearance, planning starts with knowing the exact stage of disease. If full staging, including a PET scan, confirms a single, localised lesion, chemotherapy or immunotherapy can sometimes be given first to shrink the disease before surgery is planned. Breast-conserving surgery followed by radiation, combined with chemotherapy depending on the type of disease, is one path; where the disease is multicentric, involving different parts of the same breast, breast conservation isn't possible, and a mastectomy, with reconstruction considered as part of the same surgical plan, is the outcome instead.

This article is based on a Jivo Masterclass session conducted by Dr. Sahil Bambroo, Senior Consultant, Medical Oncology, BLK-Max Super Speciality Hospital, New Delhi. The article has been summarised with the assistance of an AI tool from the original masterclass recording. Watch the full Masterclass recording

Looking for a breast cancer or medical oncology consultation or a second opinion? Get in touch with the Jivo team